BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36828805)

  • 21. Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia.
    Yoshino N; Kimura SI; Matsuoka A; Meno T; Ishikawa T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Misaki Y; Yoshimura K; Gomyo A; Okada Y; Tamaki M; Akahoshi Y; Kusuda M; Kameda K; Tanihara A; Wada H; Nakasone H; Kako S; Kanda Y
    J Infect Chemother; 2023 Apr; 29(4):384-390. PubMed ID: 36669687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
    Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
    Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sézary syndrome.
    Wu PA; Kim YH; Lavori PW; Hoppe RT; Stockerl-Goldstein KE
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):982-90. PubMed ID: 19589488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study.
    Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C;
    Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab administration within 6 months of T cell-depleted allogeneic SCT is associated with prolonged life-threatening cytopenias.
    McIver Z; Stephens N; Grim A; Barrett AJ
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1549-56. PubMed ID: 20580848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective analysis of fluoroquinolone prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Simondsen KA; Reed MP; Mably MS; Zhang Y; Longo WL
    J Oncol Pharm Pract; 2013 Dec; 19(4):291-7. PubMed ID: 23184539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant.
    Hwang JP; Ahmed S; Ariza-Heredia EJ; Duan Z; Zhao H; Schmeler KM; Ramondetta L; Parker SL; Suarez-Almazor ME; Ferrajoli A; Shih YT; Giordano SH; Chiao EY
    Biol Blood Marrow Transplant; 2018 May; 24(5):1094-1098. PubMed ID: 29378304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem-cell transplantation for chronic lymphocytic leukemia: the 1999 perspective.
    Dreger P; Michallet M; Schmitz N
    Ann Oncol; 2000; 11 Suppl 1():49-53. PubMed ID: 10707779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies.
    Celebi H; Akan H; Akçağlayan E; Ustün C; Arat M
    Bone Marrow Transplant; 2000 Jul; 26(2):211-4. PubMed ID: 10918433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients?
    Massaro KS; Macedo R; de Castro BS; Dulley F; Oliveira MS; Yasuda MA; Levin AS; Costa SF
    Infection; 2014 Dec; 42(6):1023-32. PubMed ID: 25263811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.
    Hosing C; Saliba RM; McLaughlin P; Andersson B; Rodriguez MA; Fayad L; Cabanillas F; Champlin RE; Khouri IF
    Ann Oncol; 2003 May; 14(5):737-44. PubMed ID: 12702528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapy.
    de Mooij CEM; van der Velden WJFM; de Haan AFJ; Fazel S; van Groningen LFJ; Blijlevens NMA
    Bone Marrow Transplant; 2022 Sep; 57(9):1373-1381. PubMed ID: 35661156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.
    Anagnostopoulos A; Hari PN; Pérez WS; Ballen K; Bashey A; Bredeson CN; Freytes CO; Gale RP; Gertz MA; Gibson J; Goldschmidt H; Lazarus HM; McCarthy PL; Reece DE; Vesole DH; Giralt SA
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):845-54. PubMed ID: 16864055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies.
    Branson K; Chopra R; Kottaridis PD; McQuaker G; Parker A; Schey S; Chakraverty RK; Craddock C; Milligan DW; Pettengell R; Marsh JC; Linch DC; Goldstone AH; Williams CD; Mackinnon S
    J Clin Oncol; 2002 Oct; 20(19):4022-31. PubMed ID: 12351600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.
    Castagnola E; Fontana V; Caviglia I; Caruso S; Faraci M; Fioredda F; Garrè ML; Moroni C; Conte M; Losurdo G; Scuderi F; Bandettini R; Tomà P; Viscoli C; Haupt R
    Clin Infect Dis; 2007 Nov; 45(10):1296-304. PubMed ID: 17968824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptococcal meningitis post autologous stem cell transplantation.
    Chaaban S; Wheat LJ; Assi M
    Transpl Infect Dis; 2014 Jun; 16(3):473-6. PubMed ID: 24750320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study.
    Shah NN; McClellan W; Flowers CR; Lonial S; Khoury H; Waller EK; Langston A; Nooka AK
    Infect Control Hosp Epidemiol; 2017 Jun; 38(6):651-657. PubMed ID: 28330512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation.
    de la Cámara R; Martino R; Granados E; Rodriguez-Salvanés FJ; Rovira M; Cabrera R; López J; Parody R; Sierra J; Fernández-Rañada JM; Carreras E
    Bone Marrow Transplant; 2000 Aug; 26(3):291-8. PubMed ID: 10967568
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.